EVerZom Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $1.03M

  • Investors
  • 18

EVerZom General Information

Description

Developer of regenerative biologics treatment designed for tissue healing and organ restoration. The company integrates cell modification, high-yield exosome generation, molecular loading, and formulation processes, enabling healthcare professionals to access patent-protected extracellular vesicle therapeutics with enhanced therapeutic potency, improved biodistribution, reduced immunogenicity, and potential for application across digestive disorders and organ damage indications.

Contact Information

Website
www.everzom.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 45 Rue des Saints-Pères
  • 75006 Paris
  • France
+33 06
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 45 Rue des Saints-Pères
  • 75006 Paris
  • France
+33 06

EVerZom Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EVerZom Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Equity Crowdfunding 02-Jul-2025 $1.03M Completed Generating Revenue
10. Grant 17-Jun-2025 Completed Generating Revenue
9. Accelerator/Incubator Completed Generating Revenue
8. Later Stage VC 08-Jun-2025 Completed Generating Revenue
7. Grant 16-Jun-2021 Completed Generating Revenue
6. Seed Round 03-Dec-2020 Completed Generating Revenue
5. Grant 13-Dec-2019 Completed Generating Revenue
4. Accelerator/Incubator 01-Jul-2019 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
To view EVerZom’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

EVerZom Patents

EVerZom Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4788352-A1 Combination of extracellular vesicles and chemotherapeutic agent and uses thereof for the treatment of cancers such as peritoneal carcinomatosis Pending 02-Oct-2023
WO-2025073799-A1 Combination of extracellular vesicles and chemotherapeutic agent and uses thereof for the treatment of cancers such as peritoneal carcinomatosis Inactive 02-Oct-2023

EVerZom Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EVerZom Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
France 2030 Government
Audacia Growth/Expansion Minority
Capital Cell PE-Backed Company Minority
Capital Grand Est PE/Buyout Minority
Sorbonne Venture Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

EVerZom FAQs

  • When was EVerZom founded?

    EVerZom was founded in 2019.

  • Where is EVerZom headquartered?

    EVerZom is headquartered in Paris, France.

  • What is the size of EVerZom?

    EVerZom has 24 total employees.

  • What industry is EVerZom in?

    EVerZom’s primary industry is Drug Discovery.

  • Is EVerZom a private or public company?

    EVerZom is a Private company.

  • What is the current valuation of EVerZom?

    The current valuation of EVerZom is .

  • What is EVerZom’s current revenue?

    The current revenue for EVerZom is .

  • How much funding has EVerZom raised over time?

    EVerZom has raised $15.1M.

  • Who are EVerZom’s investors?

    France 2030, Audacia, Capital Cell, Capital Grand Est, and Sorbonne Venture are 5 of 18 investors who have invested in EVerZom.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process